Novel pathophysiological insights in autoimmune myasthenia gravis

重症肌无力 自身抗体 医学 免疫学 自身免疫 免疫疗法 疾病 自身免疫性疾病 剧目 胸腺切除术 生物信息学 生物 免疫系统 抗体 病理 物理 声学
作者
Gianvito Masi,Kevin C. O’Connor
出处
期刊:Current Opinion in Neurology [Lippincott Williams & Wilkins]
卷期号:35 (5): 586-596 被引量:26
标识
DOI:10.1097/wco.0000000000001088
摘要

PURPOSE OF REVIEW: This review summarizes recent insights into the immunopathogenesis of autoimmune myasthenia gravis (MG). Mechanistic understanding is presented according to MG disease subtypes and by leveraging the knowledge gained through the use of immunomodulating biological therapeutics. RECENT FINDINGS: The past two years of research on MG have led to a more accurate definition of the mechanisms through which muscle-specific tyrosine kinase (MuSK) autoantibodies induce pathology. Novel insights have also emerged from the collection of stronger evidence on the pathogenic capacity of low-density lipoprotein receptor-related protein 4 autoantibodies. Clinical observations have revealed a new MG phenotype triggered by cancer immunotherapy, but the underlying immunobiology remains undetermined. From a therapeutic perspective, MG patients can now benefit from a wider spectrum of treatment options. Such therapies have uncovered profound differences in clinical responses between and within the acetylcholine receptor and MuSK MG subtypes. Diverse mechanisms of immunopathology between the two subtypes, as well as qualitative nuances in the autoantibody repertoire of each patient, likely underpin the variability in therapeutic outcomes. Although predictive biomarkers of clinical response are lacking, these observations have ignited the development of assays that might assist clinicians in the choice of specific therapeutic strategies. SUMMARY: Recent advances in the understanding of autoantibody functionalities are bringing neuroimmunologists closer to a more detailed appreciation of the mechanisms that govern MG pathology. Future investigations on the immunological heterogeneity among MG patients will be key to developing effective, individually tailored therapies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
权瑞松的应助被elysia采纳,获得10
1秒前
zhangxinyi发布了新的文献求助10
2秒前
2秒前
所所的应助被Czz采纳,获得10
3秒前
zz完成签到,获得积分10
3秒前
3秒前
风趣笙完成签到,获得积分10
4秒前
斯文败类的应助被撝谦采纳,获得10
4秒前
科研通AI65的应助被青年才俊采纳,获得10
4秒前
辞旧完成签到,获得积分10
5秒前
伶俐的念寒完成签到,获得积分10
5秒前
慕青的应助被esdeath采纳,获得10
5秒前
赘婿的应助被六层楼采纳,获得10
5秒前
JIA完成签到,获得积分10
6秒前
7秒前
huihui发布了新的文献求助10
8秒前
绝世完成签到,获得积分10
8秒前
8秒前
qq发布了新的文献求助10
8秒前
陶万军完成签到 ,获得积分10
8秒前
9秒前
Nole的应助被李麟采纳,获得10
10秒前
华哥完成签到,获得积分10
10秒前
11秒前
王宇洁完成签到,获得积分20
11秒前
汉堡包的应助被小汤不圆采纳,获得10
11秒前
稳重的傲芙完成签到,获得积分10
11秒前
11秒前
12秒前
12秒前
13秒前
13秒前
郑睿涛发布了新的文献求助10
14秒前
汉堡包的应助被elysia采纳,获得10
14秒前
15秒前
QiWangzhi完成签到,获得积分10
15秒前
LY关闭了LY的文献求助
15秒前
16秒前
orixero的应助被坦率的凉面采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183739
求助须知:如何正确求助?哪些是违规求助? 9572996
关于积分的说明 21828615
捐赠科研通 7780904
什么是DOI,文献DOI怎么找? 3434101
关于科研通互助平台的介绍 2558294
邀请新用户注册赠送积分活动 2480564